Rela M, Battula N, Madanur M, Mieli-Vergani G, Dhawan A, Champion M, Raiman J, Heaton N
King's College London School of Medicine at King's College Hospital, London, UK.
Am J Transplant. 2007 Sep;7(9):2200-3. doi: 10.1111/j.1600-6143.2007.01899.x.
Orthotopic liver transplantation (OLT) is an established treatment for patients with liver-based metabolic disorders that produce structural and functional impairment. Auxiliary liver transplantation (ALT) has been proposed as an alternative approach due to the potential advantage of preserving the native liver that could be used for future gene therapy and also serves as a back-up should the graft fail. The aim of our study was to determine if ALT has the long-term potential to correct the underlying abnormality in propionic acidemia (PA). A retrospective analysis was performed on graft function, metabolic parameters and effects on development in a child who underwent ALT for PA at our institute. The clinical and biochemical parameters are near normal with no diet restrictions and with good graft survival. A normal growth and an acceptable neurological and psychomotor development were achieved in the child. ALT is feasible and provides adequate liver mass to prevent metabolic decompensation in PA.
原位肝移植(OLT)是治疗患有导致结构和功能损害的肝脏代谢紊乱患者的既定疗法。由于保留天然肝脏具有潜在优势,辅助性肝移植(ALT)被提议作为一种替代方法,保留的天然肝脏可用于未来的基因治疗,并且在移植失败时还可作为备用。我们研究的目的是确定ALT是否具有长期纠正丙酸血症(PA)潜在异常的可能性。对在我们研究所接受PA的ALT治疗的一名儿童的移植功能、代谢参数及其对发育的影响进行了回顾性分析。临床和生化参数接近正常,无需饮食限制,移植存活率良好。该儿童实现了正常生长以及可接受的神经和精神运动发育。ALT是可行的,并且能提供足够的肝脏质量以防止PA患者出现代谢失代偿。